VENMAX
VENMAX DRUGS AND PHARMACEUTICAHealthcare
LTP
18
CHG · %
+0.64 (+3.69%)
VOL · TODAY
22.58K
PREV CLOSE
17.36
Today's range17.12 · 19
18
52-week range6.27 · 36.96
18
Loading candles…
Venmax Drugs & Pharmaceuticals Ltd, incorporated in 1998 and headquartered in Hyderabad, India, operates primarily in the IT & ITES and pharmaceutical industries. The company is engaged in IT & ITES services while also focusing on the manufacturing and trading of pharmaceutical products, drug intermediates, and active pharmaceutical ingredients (APIs). Its business segments encompass both IT & ITES services and pharmaceutical manufacturing and trading. Venmax Drugs & Pharmaceuticals Ltd conducts its operations within India. There are no publicly available details on its founders, key management, subsidiaries, or stock exchange listings. Sources show some discrepancy regarding its primary business focus, with one indicating IT & ITES services and another emphasizing pharmaceutical manufacturing and trading.
VENMAX is not part of any active scan today.
This page is a live market overview for VENMAX DRUGS AND PHARMACEUTICA (VENMAX) on the BSE. As a listed security, VENMAX DRUGS AND PHARMACEUTICA is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for VENMAX before placing trades on tick2trade.
As of the latest feed, VENMAX last traded at ₹18 on BSE, up ₹0.64 (3.69%) from the previous close of ₹17.36. Today's session range is ₹17.12 – ₹19, against a 52-week band of ₹6.27 – ₹36.96. Traded volume today stands at 22.58K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for VENMAX in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether VENMAX is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for VENMAX DRUGS AND PHARMACEUTICA before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in VENMAX. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated VENMAX option chain page linked from this overview.
// similar in healthcare314 total